Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Memorial Sloan-Kettering Cancer Center |
---|---|
Information provided by: | Memorial Sloan-Kettering Cancer Center |
ClinicalTrials.gov Identifier: | NCT00605488 |
See where the dye-like material (FACBC) goes in your body and how long it stays in your body. See how much of the dye-like material is picked up by your tumor Compare the FACBC pictures with other pictures (such as FDG PET scan) that were obtained as part of your standard imaging evaluation.
Condition | Intervention |
---|---|
Breast Cancer Head and Neck Cancer Prostate Cancer |
Procedure: novel PET tracer FACBC |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label, Single Group Assignment, Efficacy Study |
Official Title: | Pilot Study Investigating the Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer |
Estimated Enrollment: | 20 |
Study Start Date: | April 2006 |
Estimated Study Completion Date: | April 2010 |
Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Pet Scan
|
Procedure: novel PET tracer FACBC
Two IV catheters (heplock) will be placed in your forearms for injection of the dye-like material (FACBC) and blood sampling. An IV blood sample and a urine sample will be taken for testing. These samples will be used to measure the dye, FACBC, in blood and urine. You will be placed in the PET machine, where FACBC will be injected slowly over 30 seconds. Pictures of one region of your body will be taken for up to 60 minutes. Depending on your condition, your actual picture time may be shorter. You will come out of the scanner to stretch, walk around or sit in a chair. An optional urine sample and an IV blood sample will also be taken at this time. Again, these samples will be used to measure the dye, FACBC, in blood and urine. This will be followed by a picture of your body from the neck to the upper thighs. This picture will take about 30 minutes.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Heiko Schöder, MD | schoderh@mskcc.org | |
Contact: Steven Larson, MD | larsons@mskcc.org |
United States, New York | |
Memorial Sloan-Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Heiko Schöder, MD schoderh@mskcc.org | |
Contact: Steven Larson, MD larsons@mskcc.org | |
Principal Investigator: Heiko Schöder, MD |
Principal Investigator: | Heiko Schöder, MD | Memorial Sloan-Kettering Cancer Center |
Responsible Party: | Memorial Sloan-Kettering Cancer Center ( Heiko Schöder, M.D. ) |
Study ID Numbers: | 06-040 |
Study First Received: | January 17, 2008 |
Last Updated: | January 8, 2009 |
ClinicalTrials.gov Identifier: | NCT00605488 |
Health Authority: | United States: Institutional Review Board |
Pet Scan |
Prostatic Diseases Genital Neoplasms, Male Skin Diseases Head and Neck Neoplasms Breast Neoplasms |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms Breast Diseases |
Neoplasms Neoplasms by Site |